ROCHE GLYCART

roche-glycart-logo

Roche Glycart develops antibody drug candidates, which include GA101, a humanized anti-CD20 monoclonal antibody to increase direct- and immune-mediated target cell death; and GA201, a humanized glycoengineered antibody for solid tumors.

#SimilarOrganizations #People #Financial #Website #More

ROCHE GLYCART

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2000-01-01

Address:
Schlieren, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.roche.ch

Total Employee:
101+

Status:
Active

Contact:
+41447556161

Total Funding:
13.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content IPv6 Google Maps


Similar Organizations

bioventix-plc-logo

Bioventix Plc

Bioventix Plc is a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies.

icos-corporation-logo

ICOS Corporation

ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products.

reset-pharmaceuticals-logo

Reset Pharmaceuticals

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

Founder


joel-jean-mairet_image

Joel Jean Mairet

Investors List

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series A - Roche Glycart

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Roche Glycart

deutsche-venture-capital_image

Deutsche Venture Capital

Deutsche Venture Capital investment in Series A - Roche Glycart

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series A - Roche Glycart

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Roche Glycart

global-life-science-ventures_image

Global Life Science Ventures

Global Life Science Ventures investment in Series A - Roche Glycart

quest-capital-management-inc_image

Quest Capital Management, Inc .

Quest Capital Management, Inc . investment in Series A - Roche Glycart

Official Site Inspections

http://www.roche.ch Semrush global rank: 1.37 M Semrush visits lastest month: 20.9 K

  • Host name: 104.17.61.116
  • IP address: 104.17.61.116
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Roche Glycart"

Roche Schweiz

Bitte beachten Sie, dass Roche Pharma (Schweiz) AG keine Verantwortung für den Zugang zu solchen Informationen übernimmt, die unter Umständen nicht mit den jeweils gültigen โ€ฆSee details»

Roche's Organizational Structure [Interactive Chart]

Introduction. Hoffman-La Roche (Roche) is a leading Swiss multinational healthcare company that operates worldwide in pharmaceuticals and medical diagnostics; it is 122 years old, is family owned, employs around 94,000 โ€ฆSee details»

Switzerland - Roche

At Roche Switzerland, we are bridging the gap between pharmaceuticals and diagnostics. Major research and development functions are located right here. At various locations in Switzerland โ€ฆSee details»

Roche - Wikipedia

Founded in 1896 by Fritz Hoffmann-La Roche, the company was known early on for producing various vitamin preparations and derivatives. In 1934, it became the first company to mass-produce synthetic vitamin C, under the brand name Redoxon. During the Second World War, Roche collaborated with the Nazi regime in Germany and used forced labour in its German and Polish-based faโ€ฆSee details»

Roche - Doing now what patients need next

Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. As a pioneer in healthcare, we have been committed to improving lives since the โ€ฆSee details»

Roche | Rocheโ€™s Annual Report 2024

Innovating through scientific excellence at the Roche site in Basel The new Roche pRED Center in Basel exemplifies the future of transformative research. This state-of-the-art facility fosters โ€ฆSee details»

Pharma R&D - Basel, Switzerland - Roche

In Basel, at Rocheโ€™s birthplace 125 years ago, we continue to make major investments in new research facilities that will last way into the future. More than half of pRED scientists are based here, in the heart of Switzerlandโ€™s rich life โ€ฆSee details»

About Roche Switzerland

Roche offers a working environment that gives employees the opportunity to build their careers and follow their interests. The key to a strong and successful workforce is diversity. With โ€ฆSee details»

About us - Roche

Basel has been the headquarters of the Roche Group since our company was founded in 1896. Although we are active in more than one hundred countries today, our roots are here in โ€ฆSee details»

Our business - Roche

Rocheโ€™s success is rooted in its set up โ€“ it is led by science and designed for innovation. We foster a diversity of scientific approaches and embrace innovative ideas. Combining that with โ€ฆSee details»

About Roche

Since our founding over 125 years ago, Roche has grown into one of the worldโ€™s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major โ€ฆSee details»

Our Locations - Roche

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.See details»

Governance - Roche

Roche is committed to serving all its stakeholders. As a basis for the successful implementation of this commitment our Corporate Governance principles accordingly put the focus of our โ€ฆSee details»

Swiss pharmaceuticals company Roche announces $50B โ€ฆ

3 days ago Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and create 12,000 jobs. ... The Associated Press is an โ€ฆSee details»

Swiss pharma giant Roche to invest $50bn in US within five years

3 days ago More Rocheโ€™s big bet on big diseases . This content was published on Oct 20, 2024 Swiss pharma giant Roche is the latest company to refocus its R&D investment on diseases โ€ฆSee details»

Über Roche Schweiz

Roche bietet ein Arbeitsumfeld, das Mitarbeiter:innen die Möglichkeit bietet, ihre Karriere aufzubauen und ihren Interessen zu folgen. Der Schlüssel zu einer starken und erfolgreichen โ€ฆSee details»

US tariffs pressure Swiss pharma powerhouse - SWI swissinfo.ch

5 hours ago More Swiss pharma giant Roche to invest $50bn in US within five years . This content was published on Apr 22, 2025 After Novartis, fellow Swiss pharmaceutical company โ€ฆSee details»

Sustainability - Roche

Roche is committed to integrating health impact for all throughout the product lifecycle to ensure better health outcomes for all patients, from comprehensive clinical trial populations, better โ€ฆSee details»

Roche Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oct 29, 2024 Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas. It operates through two segments: Pharmaceuticals โ€ฆSee details»

Roche | Roche Pharma

Die Roche Pharma (Schweiz) AG ist die Schweizer Landesgesellschaft der Roche und ihre rund 160 Mitarbeiter:innen sind dafür besorgt, dass Patient:innen in der Schweiz Zugang zum โ€ฆSee details»

linkstock.net © 2022. All rights reserved